Literature DB >> 8160998

Direct effects of intravenous anesthetics on pulmonary vascular resistance in the isolated rat lung.

G F Rich1, C M Roos, S M Anderson, M O Daugherty, D R Uncles.   

Abstract

We determined the direct effects of thiopental, ketamine, midazolam, etomidate, and propofol on pulmonary vascular resistance (PVR), the relationship of the direct effects to the baseline PVR, and the possible interaction with functional endothelium. The intravenous anesthetics were injected randomly into 1) endothelium-intact isolated rat lungs which were either unconstricted or constricted with angiotensin II (n = 10), and 2) lungs with endothelial injury produced by electrolysis (n = 10). In endothelium-intact lungs thiopental (0.5 and 5.0 mg/kg) and etomidate (3.0 mg/kg) significantly (P < 0.05) increased PVR by 3% +/- 1%, 30% +/- 7%, and 29% +/- 5%, respectively. Ketamine (3.0 and 100 mg/kg) and propofol (20 mg/kg) significantly (P < 0.05) decreased the PVR by 6% +/- 1%, 15% +/- 1%, and 8% +/- 1%, respectively. Midazolam (0.3 and 3.0 mg/kg) and smaller doses of etomidate (0.3 mg/kg) and propofol (2.0 mg/kg) did not affect PVR. These responses did not vary with the baseline PVR over a twofold range. The effects of thiopental, ketamine, etomidate, and midazolam were not altered by endothelial injury. In contrast to the vasodilation produced by propofol in normal lungs, propofol (20 mg/kg) significantly (P < 0.05) increased the PVR by 8% +/- 2% after endothelial injury. In conclusion, this study demonstrates that thiopental and etomidate are direct pulmonary vasoconstrictors, ketamine and propofol are direct pulmonary vasodilators, and midazolam has no direct effects in the isolated rat lung. Further, these effects on pulmonary vasculature do not vary with baseline PVR, and only propofol appears to have endothelium-dependent effects.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8160998     DOI: 10.1213/00000539-199405000-00022

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  8 in total

1.  [Effects of propofol combined with indomethacin on contraction of isolated human pulmonary arteries].

Authors:  Ning Hao; Chun-Yu Deng; Su-Juan Kuang; Jue Ma; Guang-Yan Zhang; Jian-Xiu Cui
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-03-20

2.  Vasopressin-induced constriction of the isolated rat occipital artery is segment dependent.

Authors:  Stephen P Chelko; Chad W Schmiedt; Tristan H Lewis; Stephen J Lewis; Tom P Robertson
Journal:  J Vasc Res       Date:  2013-10-29       Impact factor: 1.934

3.  The comparison of the effect of three anesthetic induction regimens on the arterial oxygen saturation in children with tetralogy of fallot undergoing cardiac surgery.

Authors:  A R Tavakollian; E Allahyary
Journal:  Iran Red Crescent Med J       Date:  2011-10-01       Impact factor: 0.611

4.  Ketamine inhibits lung fluid clearance through reducing alveolar sodium transport.

Authors:  Yong Cui; Hongguang Nie; Hong Ma; Lei Chen; Lin Zhang; Junke Wang; Honglong Ji
Journal:  J Biomed Biotechnol       Date:  2011-10-03

5.  The bifunctional effect of propofol on thromboxane agonist (U46619)-induced vasoconstriction in isolated human pulmonary artery.

Authors:  Ning Hao; Wang Zhaojun; Sujuan Kuang; Guangyan Zhang; Chunyu Deng; Jue Ma; Jianxiu Cui
Journal:  Korean J Physiol Pharmacol       Date:  2017-10-30       Impact factor: 2.016

Review 6.  Pulmonary hypertension and cardiac anesthesia: Anesthesiologist's perspective.

Authors:  Manjula Sudeep Sarkar; Pushkar M Desai
Journal:  Ann Card Anaesth       Date:  2018 Apr-Jun

7.  Perioperative anesthesiological management of patients with pulmonary hypertension.

Authors:  Jochen Gille; Hans-Jürgen Seyfarth; Stefan Gerlach; Michael Malcharek; Elke Czeslick; Armin Sablotzki
Journal:  Anesthesiol Res Pract       Date:  2012-10-12

8.  Effect of propofol and etomidate on normoxic and chronically hypoxic pulmonary artery.

Authors:  Nazinigouba Ouédraogo; Boutchi Mounkaïla; Huguette Crevel; Roger Marthan; Etienne Roux
Journal:  BMC Anesthesiol       Date:  2006-03-03       Impact factor: 2.217

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.